Instrument Inactif

Autres langues Panacos Pharmaceuticals, Inc. Other OTC

Actions

PANC

US69811Q1067

Recherche biotechnologique et médicale

Autres langues

30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference
30/11/-1	Panacos Pharma : Panacos Reports Second Quarter 2007 Financial Results
30/11/-1	Panacos Pharma : Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference
30/11/-1	Panacos Pharma : Panacos to Report Second Quarter Results for 2007
30/11/-1	Panacos Pharma : Panacos Secures $20 Million Debt Financing
30/11/-1	Panacos Pharma : Panacos Announces Substantial Antiviral Response in Bevirimat 250 mg Cohort, Data Support Further Dose Escalation in Phase 2b Study
30/11/-1	Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference
30/11/-1	Panacos Pharma : Panacos to Present at Needham Biotech & Medtech Conference
30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Biotech Confab
30/11/-1	Panacos Pharma : Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos' Bevirimat
30/11/-1	Panacos Pharma : Panacos to Present at Bank of America Health Care Conference
30/11/-1	Panacos Pharma : Panacos Reports First Quarter 2007 Financial Results
30/11/-1	Panacos Pharma : Panacos to Present at Deutsche Bank Health Care Conference
30/11/-1	Panacos Pharma : Panacos to Report First Quarter Results for 2007
30/11/-1	Panacos Pharma : Panacos Announces New Board Member
30/11/-1	Panacos Pharma : Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
30/11/-1	Panacos Pharma : Panacos Completes Pre-clinical Studies Indicating Bevirimat Is Non-Teratogenic
30/11/-1	Panacos Pharma : Panacos Presents Progress on HIV Fusion Inhibitor Program at International AIDS Conference
30/11/-1	Panacos Pharma : Panacos to Present Data at 46th Annual ICAAC
30/11/-1	Panacos Pharma : Panacos to Present at UBS Global Life Sciences Conference
30/11/-1	Panacos Pharma : Panacos to Present at Bear Stearns Healthcare Conference
30/11/-1	Panacos Pharma : Panacos to Report Third Quarter 2006 Results
30/11/-1	Panacos Pharma : Panacos to Present at BIO Investor Forum
30/11/-1	Panacos Pharma : Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy
30/11/-1	Panacos Pharma : Panacos to Present at Citigroup Small & Mid-Cap Conference